Alan Ezekowitz, Director at Fulcrum Therapeutics, Inc. (FULC), sold 18,000 shares at $3.65 ($66K) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($66k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |